Statins and Cataracts—a Visual Insight
Authors:
- 9 December 2014
- journal article
- review article
- Published by Springer Nature in Current Atherosclerosis Reports
- Vol. 17 (2) , 1-8
Abstract
Cataract is the leading cause of visual impairment, other than uncorrected refractive errors, and the number one cause of preventable blindness worldwide. Common adverse events of statins include statin-related muscle toxicity, elevation of transaminases, diabetes, and possible association with cancer. Publications on the relationship of cataract to statins have reported inconsistent findings. A meta-analysis indicated a 19 % decrease in cataract among statin users. The pleiotropic effects of statins including effects on inflammation and oxidation may mediate a decrease in the rate of cataract formation. On the other hand, bidirectional effects of statins on oxidation and inhibition of appropriate lens epithelial cell development may promote cataractogenesis. Younger age and longer duration of statin therapy was associated with greater benefit while a benefit was not observed among older persons. A definitive way to settle the issue of the relationship of statins to cataract is to perform a randomized clinical trial or include cataract as an end point in epidemiologic studies. An increased risk of cataract may be balanced by the marked benefits of statins for those at high risk for cardiovascular events, while a decreased risk may help increase adherence to statin therapy.Keywords
This publication has 46 references indexed in Scilit:
- Lipid Peroxidation and the Total Antioxidant Status in the Pathogenesis of Age Related and Diabetic Cataracts: A Study on the Lens and BloodJournal of Clinical and Diagnostic Research, 2013
- Statin therapy and the risk for diabetes among adult women: do the benefits outweigh the risk?Therapeutic Advances in Cardiovascular Disease, 2012
- Functions of Cholesterol and the Cholesterol Bilayer Domain Specific to the Fiber-Cell Plasma Membrane of the Eye LensThe Journal of Membrane Biology, 2011
- Role of Ultraviolet Irradiation and Oxidative Stress in Cataract Formation—Medical Prevention by Nutritional Antioxidants and Metabolic AgonistsEye & Contact Lens: Science & Clinical Practice, 2011
- Lipids and the ocular lensJournal of Lipid Research, 2010
- Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trialsThe Lancet, 2010
- The Potential Relevance of the Multiple Lipid-Independent (Pleiotropic) Effects of Statins in the Management of Acute Coronary SyndromesJACC, 2005
- PLEIOTROPIC EFFECTS OF STATINSAnnual Review of Pharmacology and Toxicology, 2005
- Incidence of age-related cataract over a 10-year intervalOphthalmology, 2002
- The Effect of Atorvastatin on the Human Lens After 52 Weeks of TreatmentJournal of Cardiovascular Pharmacology and Therapeutics, 1998